Beijing Balance Medical shareholders approve extensive governance reforms

Beijing Balance Medical Technology Co., Ltd. announced that its first extraordinary general meeting of shareholders for 2025, held on September 16, 2025, successfully passed all 14 proposed resolutions. A total of 40 shareholders and their proxies attended, representing 95,550,844 voting shares, or 69.3663% of the company's total voting rights. The meeting was convened by the board of directors and presided over by Ms. Jin Can.

Key resolutions approved include the abolition of the supervisory board, changes to the registered capital, and amendments to the company's articles of association. Shareholders also endorsed significant revisions to several internal governance documents, including rules for shareholder meetings, board meetings, independent director work systems, external guarantee management, and related party transaction management. The amendments also covered profit distribution, major operating and investment decision-making, cumulative voting implementation, and the conduct of controlling shareholders and actual controllers.

All proposals received overwhelming support, with most passing with over 99% of votes in favor. Specifically, proposals 2, 3, and 4, which required a two-thirds majority, were also successfully passed. Shanghai Junlan Law Firm, represented by attorneys Jin Jian and He Mengqi, affirmed that the meeting's convening, procedures, and resolutions were in compliance with relevant laws and the company's articles of association.